A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
WO2007099559A2
Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use
WO2004108114A2
Anti-fungal composition and a process for its manufacture
WO2005074889A1
Novel compositions of taxol derivatives and the process for the manufacture thereof
AU2003260943A1
Improved novel, clear, painless preparation of propofol
WO03035063A1
Novel preparation of selective cyclooxygenase ii inhibitors
CN1561210A
Preparation of selective epoxide hydrolase II inhibitor
BR0213001A
Cyclooxygenase ii Selectives
WO0174370A1
Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera
WO0100251A1
Antiseptic and antimicrobial pharmaceutical preparation of feracrylum
AU4428900A
Novel injectable muscle relaxant formulations
AU4609200A
Novel injectable antimalarial compositions of artemisinin
WO0072848A1
Composition comprising (±)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1h,5h)-pyrimidinedione dissolved in 2,5-di-o-methyl-1,4:3,6-dianhydro-d-glucitol
WO0072884A1
A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
WO0044369A1
Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent
